Intellia Therapeutics (NTLA) R&D/CAPEX US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 1 596% 4 195% 1 802% 719.3% 3 111%   7 176%  
Changes by years, y/y, % +194pp +2 600pp -2 394pp -1 082pp +2 392pp     +17.3%

Intellia Therapeutics. R&D/CAPEX, %

Intellia Therapeutics. R&D/CAPEX, changes, pp

Intellia Therapeutics (NTLA) R&D/CAPEX US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
R&D/CAPEX, % 2 625% 7 170% 4 363% 11 028% 9 647%   7 176%
Changes by years, y/y, % +343pp +4 613pp +1 829pp +8 348pp +7 022pp    
Changes by quarters, q/q, % -56pp +4 545pp -2 807pp +6 666pp -1 382pp    

Intellia Therapeutics. R&D/CAPEX, %

Intellia Therapeutics. R&D/CAPEX, changes, pp

Intellia Therapeutics. R&D/CAPEX, changes, pp